Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KB | Q9UBF8 | 5/20 | 0.40 |
| ▸ | NAMPT | P43490 | 7/20 | 0.38 |
| ▸ | CRHR1 | P34998 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628170 | 1.00 | PI4KB (0.40) | PI4KBNAMPTCRHR1ALDH1A1RXFP1 | |
| SCHEMBL20528839 | 0.89 | CRHR1 (0.42) | PI4KBCRHR1ALDH1A1MAPTHPGD | |
| SCHEMBL29644481 | 0.88 | MAPT (0.45) | CRHR1ALDH1A1MAPT | |
| SCHEMBL20529340 | 0.88 | MAPT (0.45) | CRHR1ALDH1A1MAPT | |
| SCHEMBL23395419 | 0.88 | LMNA (0.39) | PI4KBCRHR1ALDH1A1RXFP1LMNA | |
| SCHEMBL23387094 | 0.87 | PI4KB (0.38) | PI4KBCRHR1RXFP1MAPT | |
| SCHEMBL21628157 | 0.86 | PI4KB (0.46) | PI4KBMAPT | |
| SCHEMBL29644514 | 0.86 | PI4KB (0.46) | PI4KBMAPT | |
| SCHEMBL20528851 | 0.86 | CRHR1 (0.39) | PI4KBCRHR1ALDH1A1RXFP1MAPT | |
| SCHEMBL29644519 | 0.86 | CRHR1 (0.39) | PI4KBCRHR1ALDH1A1RXFP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676485-A1 | COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION | CUROVIR AB (SE) | 2026-01-14 | — | — | EP | claimed |
| WO-2024184442-A1 | COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION | CUROVIR AB (SE) | 2024-09-12 | — | — | WO | claimed |
| EP-4028131-A1 | HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY | CUROVIR AB (SE) | 2022-07-20 | — | — | EP | claimed |
| CN-110520424-B | Heteroaromatic compounds for therapy | 库洛维公司 | 2022-06-21 | — | — | CN | claimed |
| EP-4676485-A1 | COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION | CUROVIR AB (SE) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024184442-A1 | COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION | CUROVIR AB (SE) | 2024-09-12 | — | — | WO | disclosed |